NOVO NORDISK INC. for NOVO NORDISK INC.
What was lobbied
7 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Trans-Pacific Partnership (TPP): biosimilar provisions
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| MICHAEL MAWBY | — |
| STEPHEN MCGILL | — |
| CHRISTOPHER MCGOWEN | — |
| MORIAH MERKEL | — |
| SARAH ELIZABETH NORDSTROM | — |
| SHAYLAH NUNN | — |
| LAUREN ELIZABETH SEMENIUK | — |
Taxation/Internal Revenue Code TAX
H.R. 436 Protect Medical Innovation Act of 2011
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| MICHAEL MAWBY | — |
| STEPHEN MCGILL | — |
| CHRISTOPHER MCGOWEN | — |
| MORIAH MERKEL | — |
| SARAH ELIZABETH NORDSTROM | — |
| SHAYLAH NUNN | — |
| LAUREN ELIZABETH SEMENIUK | — |
Health Issues HCR
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, Special Diabetes Program reauthorization, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care in the Essential Health Benefits Package, IOM Committee on Valuing Community-Based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012 on National Diabetes Prevention Program; CMS Obesity Intervention; Healthy People 2020 Abstract; CMS CLIA Program & HIPAA Privacy Rule Patient Access to Test Reports; AHRQ regarding the USPSTF recommendation on screening and management of obesity in adults; PCORI Draft Research Agenda
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| MICHAEL MAWBY | — |
| STEPHEN MCGILL | — |
| CHRISTOPHER MCGOWEN | — |
| MORIAH MERKEL | — |
| SARAH ELIZABETH NORDSTROM | — |
| SHAYLAH NUNN | — |
| LAUREN ELIZABETH SEMENIUK | — |
Medicare/Medicaid MMM
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 6548 Medicare Diabetes Prevention Act of 2012; S 3463 Medicare Diabetes Prevention Act of 2012; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Medicaid coverage of obesity counseling and expanding provider type; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 (deficit reduction)
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| MICHAEL MAWBY | — |
| STEPHEN MCGILL | — |
| CHRISTOPHER MCGOWEN | — |
| MORIAH MERKEL | — |
| SARAH ELIZABETH NORDSTROM | — |
| SHAYLAH NUNN | — |
| LAUREN ELIZABETH SEMENIUK | — |
Budget/Appropriations BUD
S. 3295 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2013 (National Diabetes Prevention Program); HR 6482 The Preventative Health Savings Act of 2012 (modernizing cost estimates with respect to CBO scoring of preventive health legislation); and National Diabetes Prevention Program
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| MICHAEL MAWBY | — |
| STEPHEN MCGILL | — |
| CHRISTOPHER MCGOWEN | — |
| MORIAH MERKEL | — |
| SARAH ELIZABETH NORDSTROM | — |
| SHAYLAH NUNN | — |
| LAUREN ELIZABETH SEMENIUK | — |
Pharmacy PHA
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act; H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| MICHAEL MAWBY | — |
| STEPHEN MCGILL | — |
| CHRISTOPHER MCGOWEN | — |
| MORIAH MERKEL | — |
| SARAH ELIZABETH NORDSTROM | — |
| SHAYLAH NUNN | — |
| LAUREN ELIZABETH SEMENIUK | — |
Law Enforcement/Crime/Criminal Justice LAW
S. 1002 SAFE DOSES Act and HR 4223 Safe Doses Act (Modernizing criminal laws concerning theft of medical products)
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| MICHAEL MAWBY | — |
| STEPHEN MCGILL | — |
| CHRISTOPHER MCGOWEN | — |
| MORIAH MERKEL | — |
| SARAH ELIZABETH NORDSTROM | — |
| SHAYLAH NUNN | — |
| LAUREN ELIZABETH SEMENIUK | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| NOVO NORDISK FONDEN (FOUNDATION) | Denmark | Denmark | 25.5% | — |
| NOVO NORDISK A/S | Denmark | Denmark | 100.0% | — |
| NOVO A/S | Denmark | Denmark | 25.5% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.